Intricatinol synergistically enhances the anticancerous activity of cisplatin in human A549 cells via p38 MAPK/p53 signalling

In conclusion, INT has a selective anticancer potential and could synergize cytoto xicity of CIS. Therefore, the combination of INT and CIS may serve as an effective anticancer strategy for the treatment of non-small cell lung carcinoma.
Source: Apoptosis - Category: Molecular Biology Source Type: research